Blood News and Research

RSS

Can an adapted mindfulness training program improve interoception and adherence to the DASH diet?

An adapted mindfulness training program improve interoception and adherence to the DASH diet.

6 Nov 2023

Cutting-edge 'precision medicine' shows great potential to improve diabetes care

Cutting-edge “precision medicine” has great potential to advance the diagnosis, treatment and ultimate prevention of different forms of diabetes, an international coalition of scientists reports in a sweeping assessment of the state of the field around the world.

6 Nov 2023

Bayer Digital Health UKI introduces new technology to help type 2 diabetes patients manage kidney health

Bayer Digital Healthcare UKI has today announced the launch of its first digital patient support package, My Kidney Assistant, designed to provide type 2 diabetes (T2D) patients with the information and resources to help monitor and improve their kidney health.

6 Nov 2023

New exercise trial aims to improve quality of life for people with rheumatoid arthritis

Rheumatoid arthritis is an inflammatory disease that can cause severe pain and swelling of the joints.

6 Nov 2023

Life's hardships rewire the brain: Study pinpoints neural changes from adversity

Research reveals that adverse life experiences heighten amygdala response and diminish prefrontal cortex activity, indicating potential neural mechanisms of psychological vulnerability.

5 Nov 2023

Decoding long COVID, pathophysiology, epidemiology, diagnosis, and management

Comprehensive review unravels the complexities of long COVID, spanning pathophysiology to management strategies, and underscores the need for targeted therapies and early diagnosis.

5 Nov 2023

How caffeine impacts cerebral blood flow

Caffeine consumption affects cerebral blood flow in young adults, with the study showing a dose-dependent reduction in arterial velocity post-intake. This impact on the cardiovascular system suggests caffeine's vasodilatory effects on cerebral arteries.

5 Nov 2023

Sotagliflozin provides kidney and heart benefits in patients with diabetes and chronic kidney disease

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are medications that lower blood sugar levels among other effects, provide kidney- and heart-related benefits to patients with and without diabetes.

3 Nov 2023

Pregnant women in blighted neighborhoods have higher testosterone levels, study finds

Pregnant women living in blighted neighborhoods with high levels of known stressors have higher levels of testosterone – the primary sex hormone in males -- which disrupt hormone regulation and may lead to life-threatening complications during and after childbirth, according to Rutgers research.

3 Nov 2023

Albuminuria associated with subclinical coronary artery pathology in type 2 diabetes

Advances in non-invasive imaging have allowed clinicians to assess both the structure and function of coronary arteries.

3 Nov 2023

New pathway to combat cardiovascular disease identified

Research led by the University of Minnesota Medical School identified a new pathway to combat cardiovascular disease. The study was recently published in Nature Cardiovascular Research.

3 Nov 2023

Some beneficial effects of exercise may be driven by the immune system, study suggests

The connection between exercise and inflammation has captivated the imagination of researchers ever since an early 20th-century study showed a spike of white cells in the blood of Boston marathon runners following the race.

3 Nov 2023

Researchers pioneer a novel treatment for the most common autoimmune encephalitis

Researchers at DZNE and Charité - Universitätsmedizin Berlin have pioneered a novel treatment for the most common autoimmune encephalitis.

3 Nov 2023

Nutrition and aging: A two-way relationship

With so much hype in the media about miracle diets and nutritional supplements, one is invariably tempted to look for a single, food-based magic bullet that will increase the likelihood of living a longer, healthier life.

3 Nov 2023

Sparsentan may be a new treatment option for focal segmental glomerulosclerosis

Focal segmental glomerulosclerosis (FSGS) is a rare kidney disorder that affects children and adults, and can lead to kidney failure.

3 Nov 2023

Pharmacist prescribing for hypertension could save billions and millions of lives, study finds

If pharmacists had a larger role in prescribing medications to control blood pressure, they could prevent more than 15 million heart attacks, nearly 8 million strokes and more than 4 million cases each of angina and heart failure in the U.S. over 30 years, according to a new Virginia Commonwealth University-led study.

3 Nov 2023

Racial and socioeconomic integration linked to lower health care expenditure disparities

Differences in health care expenditures between Black and white adults vary substantially with the local level of racial and economic integration, and tend to be low or nonexistent in highly integrated communities, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

3 Nov 2023

AI predicts glaucoma progression in high-risk patients with high accuracy

AI (artificial intelligence) that is trained to recognize red flags in retinal images and clinical information can predict if and when people at high risk of glaucoma, usually referred to as 'glaucoma suspects,' go on to actually develop it, finds research published online in the British Journal of Ophthalmology.

3 Nov 2023

Teleworking during the pandemic linked to higher parenting stress, especially for fathers

Forty percent of parents who worked remotely during the COVID-19 pandemic reported higher parenting stress compared with only 27 percent of parents who worked onsite, reports a new survey from scientists at Northwestern University and Ann & Robert H. Lurie Children's Hospital of Chicago.

3 Nov 2023

High-impact clinical trial results to be presented at ASN Kidney Week 2023

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2023 November 1–November 5.

3 Nov 2023

Blood News and Research

Can an adapted mindfulness training program improve interoception and adherence to the DASH diet?

Cutting-edge 'precision medicine' shows great potential to improve diabetes care

Bayer Digital Health UKI introduces new technology to help type 2 diabetes patients manage kidney health

New exercise trial aims to improve quality of life for people with rheumatoid arthritis

Life's hardships rewire the brain: Study pinpoints neural changes from adversity

Decoding long COVID, pathophysiology, epidemiology, diagnosis, and management

How caffeine impacts cerebral blood flow

Sotagliflozin provides kidney and heart benefits in patients with diabetes and chronic kidney disease

Pregnant women in blighted neighborhoods have higher testosterone levels, study finds

Albuminuria associated with subclinical coronary artery pathology in type 2 diabetes

New pathway to combat cardiovascular disease identified

Some beneficial effects of exercise may be driven by the immune system, study suggests

Researchers pioneer a novel treatment for the most common autoimmune encephalitis

Nutrition and aging: A two-way relationship

Sparsentan may be a new treatment option for focal segmental glomerulosclerosis

Pharmacist prescribing for hypertension could save billions and millions of lives, study finds

Racial and socioeconomic integration linked to lower health care expenditure disparities

AI predicts glaucoma progression in high-risk patients with high accuracy

Teleworking during the pandemic linked to higher parenting stress, especially for fathers

High-impact clinical trial results to be presented at ASN Kidney Week 2023

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News